MANA asks FDA to 'accelerate' removal of unapproved drugs from US marketplace

Alma Morales Riojas, president and chief executive of MANA, a non-profit, Latina advocacy organization in the USA, has sent a letter to the Food and Drug Administration asking it to accelerate its efforts to remove unapproved drugs from the marketplace and offering to assist the agency in achieving that goal.

'When a drug is available that has been subjected to the rigorous FDA testing process and has proven safe and effective, it should be FDA's top priority to remove unapproved versions of the same drug from the market. The removal of these drugs will best protect the safety of the consumer,' she stated.

MANA expressed its appreciation for the FDA's past efforts to remove unapproved drugs from the market, while also voicing its desire to see the agency work more rapidly to eliminate the estimated thousands of unapproved drugs that remain available for purchase in the USA today.